This Article Full Text Full Text (PDF) Supplementary Data All Versions of this Article: 0008-5472.CAN-08-1821v1 69/6/2577    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Santos, J. Articles by Fernández-Piqueras, J. Search for Related Content PubMed PubMed Citation Articles by Santos, J. Articles by Fernández-Piqueras, J.

A Role for Stroma-Derived Annexin A1 as Mediator in the Control of Genetic Susceptibility to T-Cell Lymphoblastic Malignancies through Prostaglandin E₂ Secretion

¹ Departamento de Biología Celular e Inmunología, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid; ² Ciber en Enfermedades Raras y ³ Ciber en Epidemiología y Salud Pública, Ministerio de Sanidad y Consumo; ⁴ Departamento de Patología Molecular, Unidad de Epigenética del Cáncer, Centro Nacional de Investigaciones Oncológicas; ⁵ Area de Epidemiología Ambiental y Cáncer, Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain; and ⁶ Unité de Génétique des Mammifères, Institut Pasteur, Paris, France

Requests for reprints: José Fernández-Piqueras or Javier Santos, Departamento de Biología Celular e Inmunología, Centro de Biología Molecular Severo Ochoa, Nicolás Cabrera 1, 28049-Madrid, Spain. Phone: 34-91-196-4653; Fax: 34-91-196-4420; E-mail: jfpiqueras{at}cbm.uam.es.

Key Words: Thymic lymphomas • -irradiation • low-penetrance genes • thymus stroma • Annexin A1

Cancer susceptibility is essentially attributable to multiple low-penetrance genes. Using interspecific consomic and congenic mice between the tumor-resistant SEG/Pas and the tumor-sensitive C57BL/6J strains, a region on chromosome 19 involved in the genetic resistance to -irradiation–induced T-cell lymphomas (Tlyr1) has been identified. Through the development of nonoverlapping subcongenic strains, it has been further shown that Anxa1 may be a candidate resistance gene on the basis of its differential expression in thymus stroma cells after -radiation exposure. In addition, thymus stroma cells of thymic lymphomas exhibited a significant reduction in the expression levels of Anxa1. Interestingly, the activity of Anxa1 relies on prostaglandin E₂ (PGE₂) induction that brings about apoptosis in thymocytes. In fact, in vitro transfection experiments revealed that PGE₂ production was enhanced when HEK 293 cells were transfected with full-length cDNAs of Anxa1, with PGE₂ production in the cells transfected with the allele of the resistant strain (Anxa1^Tyr) being higher than that in cells transfected with the allele of the susceptible strain (Anxa1^Phe). Furthermore, the presence of this compound in the medium induced apoptosis of immature CD4⁺CD8⁺CD3^low cells in a dose-dependent manner. These results improve our knowledge of the molecular mechanisms triggering T-cell lymphoblastic lymphoma development while highlighting the relevance of the stroma in controlling genetic susceptibility and the use of PGE₂ as a new therapeutic approach in T-cell hematologic malignancies. [Cancer Res 2009;69(6):2577–87]